Regenxbio
RGNX
187 hedge funds and large institutions have $1.23B invested in Regenxbio in 2019 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 64 increasing their positions, 53 reducing their positions, and 9 closing their positions.
267% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 9
150% more funds holding in top 10
Funds holding in top 10: 2 → 5 (+3)
21% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 53
18% more capital invested
Capital invested by funds: $1.04B → $1.23B (+$190M)
11% more funds holding
Funds holding: 168 → 187 (+19)
2.04% more ownership
Funds ownership: 79.46% → 81.5% (+2%)
32% less call options, than puts
Call options by funds: $8.09M | Put options by funds: $11.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$10.6M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.06M |
| 3 |
Goldman Sachs
New York
|
+$6.36M |
| 4 |
WG
Winton Group
London,
United Kingdom
|
+$5.88M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$5.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Carmignac Gestion
Paris,
France
|
-$37.7M |
| 2 |
WM
WS Management
Jacksonville,
Florida
|
-$9.34M |
| 3 |
State Street
Boston,
Massachusetts
|
-$8.75M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.67M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$5M |
RGNX Hedge Fund Activity: Q4 2019 in Review
187 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q4 2019, worth a combined $1.23B — up 18% from $1.04B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new RGNX positions and 9 closed out — a net gain of 24 holders — while 64 added to existing stakes and 53 trimmed.
The largest buyer was Aquilo Capital Management, opening a new position worth an estimated $10.6M. The largest seller was Carmignac Gestion, cutting an estimated $37.7M.
- 187 institutional investors held Regenxbio (RGNX) as of Q4 2019, up from 168 in Q3 2019.
- Funds reported $1.23B of Regenxbio stock for Q4 2019, up 18% quarter-over-quarter.
- 33 funds opened new Regenxbio positions in Q4 2019 and 9 closed out, a net change of +24 holders.
- The largest Regenxbio buyer in Q4 2019 was Aquilo Capital Management, an estimated $10.6M added.
- The largest Regenxbio seller in Q4 2019 was Carmignac Gestion, an estimated $37.7M sold.
Based on aggregated 13F filings for Q4 2019.